Disseminated breast cancer cells that migrate to the bone release several factors, such as PTHrP, TGF-β, and IL-6, that perturb the normal bone-remodeling process to create a microenvironment that facilitates tumor engraftment in the bone. The gene discussed is IL6; the disease is breast cancer.